Elisa Gruppioni

1.2k total citations
56 papers, 703 citations indexed

About

Elisa Gruppioni is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Elisa Gruppioni has authored 56 papers receiving a total of 703 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 21 papers in Oncology and 18 papers in Molecular Biology. Recurrent topics in Elisa Gruppioni's work include Cancer Genomics and Diagnostics (10 papers), Lung Cancer Treatments and Mutations (10 papers) and Gastrointestinal Tumor Research and Treatment (8 papers). Elisa Gruppioni is often cited by papers focused on Cancer Genomics and Diagnostics (10 papers), Lung Cancer Treatments and Mutations (10 papers) and Gastrointestinal Tumor Research and Treatment (8 papers). Elisa Gruppioni collaborates with scholars based in Italy, United States and France. Elisa Gruppioni's co-authors include Michelangelo Fiorentino, Annalisa Altimari, Elena Gabusi, Barbara Corti, Antonietta D’Errico, Antonia D’Errico-Grigioni, Elisa Capizzi, Walter Franco Grigioni, Francesco Grigioni and Antonio Daniele Pinna and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Elisa Gruppioni

56 papers receiving 691 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisa Gruppioni Italy 15 274 216 159 155 136 56 703
Kenji Yorita Japan 14 260 0.9× 202 0.9× 178 1.1× 160 1.0× 126 0.9× 72 689
Seiji Naganuma Japan 16 429 1.6× 242 1.1× 193 1.2× 116 0.7× 236 1.7× 38 795
Masayuki Otsuka Japan 15 343 1.3× 300 1.4× 227 1.4× 121 0.8× 114 0.8× 73 847
Stephanie Petrillo Canada 18 394 1.4× 293 1.4× 94 0.6× 118 0.8× 216 1.6× 38 794
Tsung‐Yen Cheng Taiwan 16 264 1.0× 378 1.8× 193 1.2× 133 0.9× 130 1.0× 20 723
Christian Teschendorf Germany 12 182 0.7× 222 1.0× 75 0.5× 125 0.8× 58 0.4× 28 621
Letizia Perracchio Italy 16 382 1.4× 315 1.5× 69 0.4× 110 0.7× 168 1.2× 33 801
Karl Reinhard Aigner Germany 14 438 1.6× 482 2.2× 117 0.7× 192 1.2× 225 1.7× 63 946
Philipp‐Sebastian Koch Germany 16 348 1.3× 217 1.0× 141 0.9× 46 0.3× 140 1.0× 35 948
Jennifer A. Grabowsky United States 12 389 1.4× 274 1.3× 64 0.4× 104 0.7× 75 0.6× 29 634

Countries citing papers authored by Elisa Gruppioni

Since Specialization
Citations

This map shows the geographic impact of Elisa Gruppioni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Gruppioni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Gruppioni more than expected).

Fields of papers citing papers by Elisa Gruppioni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Gruppioni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Gruppioni. The network helps show where Elisa Gruppioni may publish in the future.

Co-authorship network of co-authors of Elisa Gruppioni

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Gruppioni. A scholar is included among the top collaborators of Elisa Gruppioni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Gruppioni. Elisa Gruppioni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maloberti, Thais, Antonio De Leo, Elisa Gruppioni, et al.. (2024). Molecular Characterization of Advanced-Stage Melanomas in Clinical Practice Using a Laboratory-Developed Next-Generation Sequencing Panel. Diagnostics. 14(8). 800–800. 3 indexed citations
2.
Giglio, Andrea De, Giulia Venturi, Alessandro Di Federico, et al.. (2024). Early monitoring of plasma KRAS G12C with digital PCR predicts antitumor response to immunotherapy or sotorasib in advanced NSCLC: A brief report. SHILAP Revista de lepidopterología. 6. 100161–100161. 3 indexed citations
3.
Giglio, Andrea De, Dario de Biase, Thais Maloberti, et al.. (2024). STK11 mutations correlate with poor prognosis for advanced NSCLC treated with first-line immunotherapy or chemo-immunotherapy according to KRAS, TP53, KEAP1, and SMARCA4 status. Lung Cancer. 199. 108058–108058. 3 indexed citations
4.
Federico, Alessandro Di, Hugo de Jonge, Andrea De Giglio, et al.. (2024). Clinical and Preclinical Activity of EGFR Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer Harboring BRAF Class 3 Mutations. JCO Precision Oncology. 8(8). e2400240–e2400240. 2 indexed citations
5.
Maloberti, Thais, Antonio De Leo, Elisa Gruppioni, et al.. (2023). Multi-Gene Next-Generation Sequencing Panel for Analysis of BRCA1/BRCA2 and Homologous Recombination Repair Genes Alterations Metastatic Castration-Resistant Prostate Cancer. International Journal of Molecular Sciences. 24(10). 8940–8940. 3 indexed citations
6.
Leo, Antonio De, Thais Maloberti, Annalisa Altimari, et al.. (2023). Expanding the Spectrum of BRAF Non-V600E Mutations in Thyroid Nodules: Evidence-Based Data from a Tertiary Referral Centre. International Journal of Molecular Sciences. 24(4). 4057–4057. 7 indexed citations
7.
Maloberti, Thais, Antonio De Leo, Michela Visani, et al.. (2022). BRAF and MLH1 Analysis Algorithm for the Evaluation of Lynch Syndrome Risk in Colorectal Carcinoma Patients: Evidence-Based Data from the Analysis of 100 Consecutive Cases. SHILAP Revista de lepidopterología. 3(3). 115–124. 3 indexed citations
8.
Dondi, Giulia, Antonio De Leo, Simona Ferrari, et al.. (2020). An Analysis of Clinical, Surgical, Pathological and Molecular Characteristics of Endometrial Cancer According to Mismatch Repair Status. A Multidisciplinary Approach. International Journal of Molecular Sciences. 21(19). 7188–7188. 20 indexed citations
9.
Giunchi, Francesca, Elisa Gruppioni, Annalisa Altimari, et al.. (2020). Similarities and Differences between Clear Cell Tubulo-Papillary and Conventional Clear Cell Renal Cell Carcinoma: A Comparative Phenotypical and Mutational Analysis. Diagnostics. 10(2). 123–123. 3 indexed citations
10.
Ricci, Costantino, Francesca Ambrosi, Marco Grillini, et al.. (2020). Next‐generation sequencing revealing TP53 mutation as potential genetic driver in dermal deep‐seated melanoma arising in giant congenital nevus in adult patients: A unique case report and review of the literature. Journal of Cutaneous Pathology. 47(12). 1164–1169. 5 indexed citations
11.
Giunchi, Francesca, Francesco Massari, Annalisa Altimari, et al.. (2020). Dual TMPRSS2:ERG Fusion in a Patient with Lung and Prostate Cancers. Diagnostics. 10(12). 1109–1109. 5 indexed citations
12.
Repaci, Andrea, Valentina Vicennati, Alexandro Paccapelo, et al.. (2019). BRAF V600E Status and Stimulated Thyroglobulin at Ablation Time Increase Prognostic Value of American Thyroid Association Classification Systems for Persistent Disease in Differentiated Thyroid Carcinoma. International Journal of Endocrinology. 2019. 1–7. 2 indexed citations
13.
Capizzi, Elisa, Filippo Gustavo Dall’Olio, Elisa Gruppioni, et al.. (2019). Clinical significance of ROS1 5’ deletions in non-small cell lung cancer. Lung Cancer. 135. 88–91. 11 indexed citations
14.
Nannini, Margherita, Giuseppe Tarantino, Valentina Indio, et al.. (2019). Molecular modelling evaluation of exon 18 His845_Asn848delinsPro PDGFRα mutation in a metastatic GIST patient responding to imatinib. Scientific Reports. 9(1). 2172–2172. 5 indexed citations
15.
Dika, Emi, Giulia Veronesi, Annalisa Altimari, et al.. (2019). BRAF, KIT, and NRAS Mutations of Acral Melanoma in White Patients. American Journal of Clinical Pathology. 153(5). 664–671. 23 indexed citations
16.
Mandrioli, Matteo, Laura Mastrangelo, Michele Masetti, et al.. (2017). Characterization of malignant gastrointestinal stromal tumors—a single center experience. Journal of Gastrointestinal Oncology. 8(6). 1037–1045. 4 indexed citations
17.
Storci, Gianluca, Sabrina De Carolis, Alessio Papi, et al.. (2013). Slug/β-Catenin–Dependent Proinflammatory Phenotype in Hypoxic Breast Cancer Stem Cells. American Journal Of Pathology. 183(5). 1688–1697. 17 indexed citations
18.
Capizzi, Elisa, Elisa Gruppioni, Antonia D’Errico Grigioni, et al.. (2008). Real Time RT-PCR Approach for the Evaluation of ERBB2 Overexpression in Breast Cancer Archival Samples: A Comparative Study With FISH, SISH, and Immunohistochemistry. Diagnostic Molecular Pathology. 17(4). 220–226. 25 indexed citations
19.
Altimari, Annalisa, Elisa Gruppioni, Elisa Capizzi, et al.. (2008). Blood Monitoring of Granzyme B and Perforin Expression After Intestinal Transplantation. Transplantation. 85(12). 1778–1783. 24 indexed citations
20.
Corti, Barbara, Annalisa Altimari, Elena Gabusi, et al.. (2006). Two Years’ Experience of Acute Rejection Monitoring of Intestinal Transplant Recipients by Real-Time PCR Assessment of Granzyme B and Perforin Up-Regulation: Considerations on Diagnostic Accuracy. Transplantation Proceedings. 38(6). 1726–1727. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026